Skip to main content

Advertisement

Log in

Radiomics model and clinical scale for the preoperative diagnosis of silent corticotroph adenomas

  • Original Article
  • Published:
Journal of Endocrinological Investigation Aims and scope Submit manuscript

Abstract

Objective

Silent corticotroph adenomas (SCAs) are a subtype of nonfunctioning pituitary adenomas that exhibit more aggressive behavior. However, rapid and accurate preoperative diagnostic methods are currently lacking.

Design

The purpose of this study was to examine the differences between SCA and non-SCA features and to establish radiomics models and a clinical scale for rapid and accurate prediction.

Methods

A total of 260 patients (72 SCAs vs. 188 NSCAs) with nonfunctioning adenomas from Peking Union Medical College Hospital were enrolled in the study as the internal dataset. Thirty-five patients (6 SCAs vs. 29 NSCAs) from Fuzhou General Hospital were enrolled as the external dataset. Radiomics models and an SCA scale to preoperatively diagnose SCAs were established based on MR images and clinical features.

Results

There were more female patients (internal dataset: p < 0.001; external dataset: p = 0.028) and more multiple microcystic changes (internal dataset: p < 0.001; external dataset: p = 0.012) in the SCA group. MRI showed more invasiveness (higher Knosp grades, p ≤ 0.001). The radiomics model achieved AUCs of 0.931 and 0.937 in the internal and external datasets, respectively. The clinical scale achieved an AUC of 0.877 and a sensitivity of 0.952 in the internal dataset and an AUC of 0.899 and a sensitivity of 1.0 in the external dataset.

Conclusions

Based on clinical information and imaging characteristics, the constructed radiomics model achieved high preoperative diagnostic ability. The SCA scale achieved the purpose of rapidity and practicality while ensuring sensitivity, which is conducive to simplifying clinical work.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

Data availability

The datasets used and/or analyzed during the current study are available from the corresponding author upon reasonable request.

Abbreviations

SCA:

Silent corticotroph adenomas

NFPA:

Nonfunctioning pituitary adenoma

ACTH:

Adrenocorticotropic hormone

MMs:

Multiple microcysts

ICA:

Internal carotid artery

References

  1. Lopes MJ, Bs AN (2017) The 2017 World Health Organization classification of tumors of the pituitary gland: a summary. Acta Neuropathol 134:521

    Article  CAS  PubMed  Google Scholar 

  2. Louis DN et al (2021) The 2021 who classification of tumors of the central nervous system: a summary. Neuro Oncol 23(8):1231–1251

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Horvath E et al (1980) Silent corticotropic adenomas of the human pituitary gland: a histologic, immunocytologic, and ultrastructural study. Endocrine 98(3):617–638

    CAS  Google Scholar 

  4. Righi A et al (2016) The changing faces of corticotroph cell adenomas: the role of prohormone convertase 1/3. Endocrine 56(2):1–12

    Google Scholar 

  5. Raverot G et al (2010) Clinical, hormonal and molecular characterization of pituitary ACTH adenomas without (silent corticotroph adenomas) and with Cushing’s disease. Euro J Endocrinol. 163(1):35

    Article  CAS  Google Scholar 

  6. Cheres AE et al (2017) Perioperative hypothalamic pituitary adrenal function in patients with silent. corticotroph adenomas 20(4):471–476

    CAS  Google Scholar 

  7. Yamada S et al (2007) A study of the correlation between morphological findings and biological activities in clinically nonfunctioning pituitary adenomas. Neurosurgery 61(3):580

    Article  PubMed  Google Scholar 

  8. Cho HY et al (2010) Silent corticotroph adenomas have unique recurrence characteristics compared with other nonfunctioning. pituitary adenomas 72(5):648–653

    Google Scholar 

  9. Langlois F et al (2017) Clinical profile of silent growth hormone pituitary adenomas; higher recurrence rate compared to silent gonadotroph pituitary tumors a large single center experience. Endocrine 58:534

    Article  Google Scholar 

  10. Arman J et al (2013) A comprehensive long-term retrospective analysis of silent corticotrophic adenomas vs hormone-negative adenomas. Neurosurgery 1:17–18

    Google Scholar 

  11. Jiang S, Zhu J, Feng M, Yao Y, Deng K, Xing B, Lian W, Wang R, Bao X (2021) Clinical profiles of silent corticotroph adenomas compared with silent gonadotroph adenomas after adopting the 2017 WHO pituitary classification system. Pituitary 24:564–573

    Article  CAS  PubMed  Google Scholar 

  12. Cazabat L et al (2014) Silent, but not unseen:Multi-microcystic aspect on T2-weighted MRI in Silent Corticotroph Adenomas. Clinical Endocrinol 81(4):566–572

    Article  CAS  Google Scholar 

  13. Nishioka H, Inoshita N, Mete O, Asa SL, Hayashi K, Takeshita A, Fukuhara N, Yamaguchi-Okada M, Takeuchi Y, Yamada S (2015) The complementary role of transcription factors in the accurate diagnosis of clinically nonfunctioning pituitary adenomas. Endocr Pathol 26:349–355

    Article  CAS  PubMed  Google Scholar 

  14. He, W., et al., Development and Evaluation of Deep Learning-based Automated Segmentation of Pituitary Adenoma in Clinical Task. (9): p. 9.

  15. Fan Y et al (2019) Machine learning-based radiomics predicts radiotherapeutic response in patients with acromegaly. Front Endocrinol (Lausanne) 10:588

    Article  PubMed  Google Scholar 

  16. Fan Y et al (2019) Preoperative noninvasive radiomics approach predicts tumor consistency in patients with acromegaly: development and multicenter prospective validation. Front Endocrinol (Lausanne) 10:403

    Article  PubMed  Google Scholar 

  17. Ugga L et al (2019) Prediction of high proliferative index in pituitary macroadenomas using MRI-based radiomics and machine learning. Front Endocrinol 61(12):1365–1373

    Google Scholar 

  18. Cuocolo R et al (2020) Prediction of pituitary adenoma surgical consistency: radiomic data mining and machine learning on T2-weighted MRI. Neuroradiology 62:1649

    Article  PubMed  PubMed Central  Google Scholar 

  19. Ajp A et al (2020) A machine learning model to precisely immunohistochemically classify pituitary adenoma subtypes with radiomics based on preoperative magnetic resonance imaging. Sci Direct. 125:453

    Google Scholar 

  20. Bahuleyan B et al (2006) To assess the ability of MRI to predict consistency of pituitary macroadenomas. Sci Direct 20(5):324–326

    CAS  Google Scholar 

  21. Griethuysen JJMV et al (2017) Computational Radiomics System to Decode the Radiographic. Phenotype 77(21):e104–e107

    Google Scholar 

  22. Braileanu M et al (2019) Pre-operative MRI predictors of hormonal remission status post pituitary. adenoma resec 55:29–34

    Google Scholar 

  23. Hui Z, Hastie T (2012) elasticnet Elastic-Net for Sparse Estimation and Sparse PCA. Mach Learn 45:554

    Google Scholar 

  24. Breiman LJ (2001) Random forests. Mach Learn 45(1):5–32

    Article  Google Scholar 

  25. Geurts P, Ernst D, Wehenkel LJML (2006) Extremely randomized trees 63(1):3–42

    Google Scholar 

  26. Quinlan JR (1986) Induction of decision trees. Mach Learn 1(1):81–106

    Article  Google Scholar 

  27. Friedman JHJCSD (2002) Stochastic gradient boosting. Mach Learn 38(4):367–378

    Google Scholar 

  28. Schapire RE, Singer Y (2000) BoosTexter: a boosting-based system for text categorization. Mach Learn 39(2/3):135–168

    Article  Google Scholar 

  29. Gardner MW, Dorling SJA (1998) Artificial neural networks (the multilayer perceptron). A rev appl atmo sci. 32:2627–2636

    CAS  Google Scholar 

  30. Chen, T. and C. Guestrin, 2016 XGBoost, in Proceedings of the 22nd ACM SIGKDD International Conference on Knowledge Discovery and Data Mining. 785–794.

  31. Rodríguez-Pérez R, JBJC. Design, 2020 Interpretation of machine learning models using shapley values: application to compound potency and multi-target activity predictions. 34(10): 1013–1026.

  32. Sullivan L.M., J.M. Massaro, and R.B.D.A.J.S.i.M. Sr., 2010 Presentation of multivariate data for clinical use: The Framingham Study risk score functions. 23(10): 1631–1660.

  33. Woodward M (2013) Epidemiology: study design and data analysis. CRC press

  34. Fang Y, Pei Z, Chen H, Wang R, Feng M, Wei L, Li J, Zhang H, Wang S (2021) Diagnostic value of knosp grade and modified knosp grade for cavernous sinus invasion in pituitary adenomas: a systematic review and meta-analysis. Pituitary 24(3):457–464

    Article  PubMed  Google Scholar 

  35. Athanasios F et al (2018) Recurrence of Silent Corticotroph Adenomas After Primary Treatment: A Systematic Review. Meta-Analysis 4:4

    Google Scholar 

  36. Bradley KJ, Wass JAH, Turner HEJCE (2010) Non-functioning pituitary adenomas with positive immunoreactivity for ACTH behave more aggressively than ACTH immunonegative tumours but do not recur more frequently. Clinical Endocrinol 58(1):665

    Google Scholar 

  37. Li H, Zhao Q, Zhang Y, Sai K, Xu L, Mou Y et al (2021) Image-driven classification of functioning and nonfunctioning pituitary adenoma by deep convolutional neural networks. Computat Struct Biotech J 19:3077–3086

    Article  Google Scholar 

  38. Kasuki L et al (2019) Accuracy of microcystic aspect on T2 eighted MRI for the diagnosis of silent corticotroph adenomas. Clin Endocrinol 92(2):676

    Google Scholar 

Download references

Funding

This work was supported by the National Key R&D Program of China (2021YFE0114300); CAMS Innovation Fund for Medical Sciences (CIFMS 2021-I2M-1–003); Beijing Municipal Natural Science Foundation (M22013); Key-Area Research and Development Program of Guangdong Province (2021B0101420005); National High-Level Hospital Clinical Research Funding (2022-PUMCH-C-012).

Author information

Authors and Affiliations

Authors

Contributions

HW and WZ contributed equally to the present study. MF initiated the study. FF collected MR images, HW, WZ, and MF performed segmentation. YY, KD, LL, and XB helped collect neurosurgery data and endocrinology data. HW and YF established the model. SL, SJ, and RW wrote the draft. All authors revised the manuscript critically. All authors approved the final version of the manuscript.

Corresponding authors

Correspondence to R. Wang or M. Feng.

Ethics declarations

Conflict of interest

We declare that we have no conflicts of interest.

Ethical approval

This retrospective study was approved by the ethical review committee of the Peking Union Medical College Hospital.

Informed consent

The requirement for informed consent was waived because of the retrospective nature of the study.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Wang, H., Chang, J., Zhang, W. et al. Radiomics model and clinical scale for the preoperative diagnosis of silent corticotroph adenomas. J Endocrinol Invest 46, 1843–1854 (2023). https://doi.org/10.1007/s40618-023-02042-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40618-023-02042-2

Keywords

Navigation